People frequently use medical cannabis to treat anxiety, depression and PTSD, but two new reviews show there is little ...

(Anastassiya Bezhekeneva/Getty Images) A large umbrella review has found no strong evidence to date that medicinal cannabis ...

The voter-approved Nebraska Medical Cannabis Commission is banking on the Legislature to pass the state’s first-ever bill related to a medical cannabis program as a key step toward a regulated, ...

By Sriparna Roy March 16 (Reuters) - Cannabis-based medicines have shown little evidence of effectiveness for treating most ...

Today marks a small step forward, but we are up against incredible odds.” By Zach Wendling, Nebraska Examiner Health care ...

Declining sales are boosting a state lawmaker's plan to repeal New York's excise tax on medical cannabis, which operators say ...

Tilray Medical, a recognized global leader in medical cannabis and a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY), today announced its largest portfolio expansion in Australia ...

A new analysis represents the largest effort yet to systematically parse all the data from high-quality clinical trials on cannabis and mental health. The evidence is lacking.

The audit also found a records management failure, violations of the Alabama Open Meetings Act, improperly adopted fee ...

Researchers have suggested it may not be effective in treating some of the most common conditions it’s prescribed for.

The largest review of medicinal cannabis to date found it doesn’t effectively treat anxiety, depression, or PTSD—despite millions using it for those reasons. Researchers warn it could even make mental ...

New York senators have approved a bill related to reciprocity for out-of-state medical marijuana patients and the ...